ACE1831 is an allogeneic gamma delta T cell therapy candidate targeting CD20-expressing cells currently being investigated in non-Hodgkin's lymphoma (NHL) The planned clinical study will be executed ...
Nattawat Klomjit, MD, shares insights on managing IgA nephropathy and C3 glomerulopathy, including innovative drugs that target kidney inflammation and proteinuria.
US FDA approves Johnson & Johnson MedTech’s OTTAVA robotic surgical system: New Brunswick, New Jersey Friday, November 15, 2024, 12:00 Hrs [IST] Johnson & Johnson MedTech, a glo ...